BioSpace News Archive

The global market for dermatological drugs covers within its purview a large number of drug classes that are employed for treating the vast variety of diseases related to skin, nail, genital membranes, and hair affecting millions of people globally.

ACCORD is the second pivotal trial of AXS-05 in Alzheimer’s disease agitation No treatments are currently approved for Alzheimer’s disease agitation

Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina -based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-onco

FYR Diagnostics , a Missoula -based biotech company, has executed a contract with the State of Montana that will increase statewide COVID-19 testing capacity and reduce the time patients must wait to receive results. Adding FYR as a primary t

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, announced today a 1-for-35 reverse split of its Class A common stock, par value $0.001 (“common stock”), effective at 5:00 pm Eastern time today. Beginning on January 4, 2021, the Company’s common stock will trade on The Nasdaq Capital Market and the Toronto Stock Exchange on a split adjusted basis. Upon e